NCT00180297 - Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Ventricular TachycardiaVentricular Fibrillation

Interventions

DEVICE

Endotak Reliance G

Reliance G is a defibrillation lead to be placed in the right ventricle.

Trial Locations (18)

13008

CH St. Joseph, Marseille

13385

CHU La Timone, Marseille

25030

CH Besancon, Besançon

31403

CHU Rangueil, Toulouse

34295

CHU Montpellier, Montpellier

CHU Nantes, Nantes

Nouvelle Clinique Nantaise, Nantes

37044

CHU Tours, Tours

38043

CHU Michalon, Grenoble

49033

CHU Angers, Angers

63003

CHU Clermont Ferrand, Clermont-Ferrand

75010

CHU Lariboisière, Paris

75013

CHU Pitié Salpitrière, Paris

75908

HEGP, Paris

76031

CHU Rouen, Rouen

80054

CH Amiens, Amiens

94010

CHU Henri Mandor, Créteil

Unknown

Hôpital Pontchaillou, Rennes